Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy
Summary
Vector Science & Therapeutics announced that its board approved 206,610 stock options for certain directors. The options vest through the end of 2026, carry a C$1.69 exercise price, and remain exercisable for five years. The grant still needs approval from the TSX Venture Exchange. The company says it develops biomechanical devices and active localized drug delivery platforms for precision clinical interventions.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected